Nilotinib

Red

Brand Name(s):Tasigna

Indication:Chronic myelogenous leukaemia (CML), Resistant Philadelphia chromosome-positive CML

Rationale:1,2,3,8

Considered:Nov-08

Review Date:Jan-22

Comments:
NICE TA 426
Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemiaDasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia

…………………………
Drug Safety Update
Patients should be tested for hepatitis B virus before starting treatment with BCR-ABL tyrosine kinase inhibitors.
May2016